Image 1 of 1
Image 1 of 1
Image 1 of 1
Image 1 of 1
Retatrutide is an experimental drug developed for obesity treatment, targeting three hormone receptors (GLP-1, GIP, and glucagon) to promote weight loss. It has shown significant weight loss results in clinical trials, with participants losing an average of 28.7% of their body weight over 68 weeks. Retatrutide may improve liver health, support heart health, and enhance blood sugar control, making it beneficial beyond just weight loss. It targets multiple hormone pathways, which can lead to better metabolic health and reduced visceral fat.
$209 1 month supply (all injection supplies included) + one time $39 doc consult fee + $40 shipping. Upt o 3 months can be ordered at a time.
Retatrutide is an experimental drug developed for obesity treatment, targeting three hormone receptors (GLP-1, GIP, and glucagon) to promote weight loss. It has shown significant weight loss results in clinical trials, with participants losing an average of 28.7% of their body weight over 68 weeks. Retatrutide may improve liver health, support heart health, and enhance blood sugar control, making it beneficial beyond just weight loss. It targets multiple hormone pathways, which can lead to better metabolic health and reduced visceral fat.
$209 1 month supply (all injection supplies included) + one time $39 doc consult fee + $40 shipping. Upt o 3 months can be ordered at a time.